Cocooncenter has been acquired by Groupe Pharmacie Lafayette
The shareholders of Cocooncenter have sold the company to Groupe Pharmacie Lafayette.
Founded in 2005, Cocooncenter offers an assortment of parapharmaceutical products from the leading laboratory brands, dedicated to well-being. The offer includes more than 720 brands and more than 24,000 references selected by a team of specialists to guarantee product quality. Cocooncenter has put customer relations at the heart of its strategy with a dedicated service providing personalized advice and satisfaction monitoring.
Groupe Pharmacie Lafayette, owned by the fund Five Arrows Principal Investments, has been working since 2005 to make healthcare accessible to all through its four brands: Pharmacie Lafayette, Parapharmacie Lafayette, Optique Lafayette and Lafayette Medical. The group has developed a network of pharmacies that offer low prices on very wide range of products, as well as professional advice.
Oaklins’ team in France acted as advisor to the shareholders of Cocooncenter in this transaction.
Talk to the deal team
Related deals
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreMark Climate Technology has acquired Heber GmbH
Heber GmbH has been acquired by Mark Climate Technology, a specialist in climate control systems and a portfolio company of Bolster Investment Partners. This partnership strengthens the positions of both companies in the global market for innovative and sustainable climate solutions, as well as creating unique synergies. Mark Climate's expertise in standardized, scalable solutions is enhanced by Heber's emphasis on customer-specific customization.
Learn moreGrupo Veta 2017 S.L. has been acquired by MSA Mizar
The Franco-Belgian fund Kartesia has sold Grupo Veta 2017 S.L. to the Italian group MSA Mizar. Kartesia, the main shareholder of Veta+ together with its founding partner, has sold 100% of the capital. For MSA Mizar, this transaction represents the consolidation of its presence in Spain, the entry into the multi-risk claims management market and the opportunity to apply Veta+’s expertise to other European markets.
Learn more